Oxycodone to Exhibit Moderate Growth During 2018-2028 Owing to Growing Demand for Pain Management
A rise in the number of patients suffering from terminally-ill diseases, such as cancer and HIV, and a high surge in post-operative pain medication prescription is expected to boost the consumption of oxycodone as a pain medicine. According to the Center for Disease Control and Prevention, in 2013, there were 239 million surgeries conducted across the globe, out of which 69 million were conducted in the U.S. Out of all these 239 million surgeries, around 65% of the patients experienced moderate to severe post-operative pain. This factor fuels the adoption of opioid pain management drugs and indirectly expands the growth of the oxycodone market.
★
★
★
★
★
54 views • 4 slides